首页> 外文OA文献 >Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro.
【2h】

Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro.

机译:cr啶化合物对利什曼原虫前鞭毛体的细胞毒性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of mammalian and bacterial topoisomerase II inhibitors on Leishmania promastigotes was studied in vitro. Parasites were incubated with drugs, and cytotoxicity was assessed on the basis of the loss of flagellar motility and cell lysis after 48 h. 9-Aminoacridines, which are structurally related to the known antileishmanial compounds quinacrine and chlorpromazine, showed activity against the parasite at concentrations in the range of 10 to 20 microM. Adriamycin showed far less activity, while etoposide and several quinolones were inactive at 100-microM concentrations. These results demonstrate that a particular structural class of compounds is cytotoxic to Leishmania species. The unique structure-activity relationship discovered suggests that leishmanial topoisomerase II could be a useful target for chemotherapy.
机译:体外研究了哺乳动物和细菌拓扑异构酶II抑制剂对利什曼原虫前鞭毛体的影响。将寄生虫与药物一起孵育,并根据48小时后鞭毛运动力的丧失和细胞溶解情况评估细胞毒性。在结构上与已知的抗疟药奎纳克林和氯丙嗪有关的9-氨基ac啶在10至20 microM的浓度下显示出对寄生虫的活性。阿霉素显示的活性要低得多,而依托泊苷和几种喹诺酮类药物在100-microM浓度下是无活性的。这些结果证明化合物的特定结构类别对利什曼原虫物种具有细胞毒性。发现的独特的构效关系表明,利什曼体拓扑异构酶II可能是化疗的有用靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号